Lars Wallentin - Dissemin

All papers authored by Lars Wallentin

This paper was not found in any repository, but could be made available legally by the author.

Pia Davidsson

, Susanna Eketjäll, Niclas Eriksson

, Anna Walentinsson, Richard C. Becker, Anders Cavallin, Anna Bogstedt, Anna Collén, Claes Held

, Stefan James, Agneta Siegbahn, Ralph Stewart

, Robert F. Storey, Harvey White, Lars Wallentin

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Upload

This paper is made freely available by the publisher.

Gorav Batra

, Henrik Renlund

, Vijay Kunadian

, Stefan K. James

, Robert F. Storey, P. Gabriel Steg, Hugo A. Katus, Robert A. Harrington, C. Michael Gibson, Andrzej Budaj

, Agneta Siegbahn, Lars Wallentin

Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial

Download from academic.oup.com

Gorav Batra

, Suleman Aktaa

, Lars Wallentin

, Aldo P. Maggioni, Chris Wilkinson

, Barbara Casadei

, Chris P. Gale

Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

Upload

Maria Tomasdottir, Claes Held, Nermin Hadziosmanovic, Johan Westerbergh, Johan Lindbäck

, Philip E. Aylward, Andrzej Budaj, Christopher P. Cannon

, Johan Engdahl

, Christopher B. Granger, Wolfgang Koenig, Athanasios J. Manolis, Jonas Oldgren, Ralph A. H. Stewart, Emma Svennberg

and 5 other authors

Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease

Upload

2020 Raffaele De Caterina

, Giuseppe Patti, Johan Westerbergh, John Horowitz, Justin A. Ezekowitz

, Basil S. Lewis

, Renato D. Lopes, John J. V. McMurray, Dan Atar, M. Cecilia Bahit, Matyas Keltai, José L. López-Sendón, Witold Ruzyllo, Christopher B. Granger, John H. Alexander

and 1 other authors

Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial

Download from academic.oup.com

Anthony P. Carnicelli

, on behalf of the Combine Af Investigators, Hwanhee Hong

, Robert P. Giugliano, Stuart J. Connolly, John Eikelboom, Manesh R. Patel, Lars Wallentin

, David A. Morrow, Daniel Wojdyla, Kaiyuan Hua, Stefan H. Hohnloser, Jonas Oldgren, Christian T. Ruff, Jonathan P. Piccini and 3 other authors

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

Upload

Lars Wallentin

, Johan Lindbäck

, Niclas Eriksson

, Ziad Hijazi, John W. Eikelboom, Michael D. Ezekowitz

, Christopher B. Granger, Renato D. Lopes, Salim Yusuf, Jonas Oldgren

, Agneta Siegbahn

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

Download from academic.oup.com

Michael Böhm

, Martina Brueckmann, John W. Eikelboom, Michael Ezekowitz, Mandy Fräßdorf

, Ziad Hijazi, Stefan H. Hohnloser, Felix Mahfoud

, Roland E. Schmieder, Helmut Schumacher, Lars Wallentin

, Salim Yusuf

Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial

Download from academic.oup.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Lars Wallentin